Creasallis
4 known investors
Creasallis develops CreaTap, a patented "plug-and-play" antibody modification technology that improves the penetration of antibody-based drugs into solid tumours, applicable to monoclonal, bispecific, and antibody-drug conjugates. It serves biopharmaceutical companies developing oncology therapeutics and is also building its own suite of antibody therapeutics with enhanced tumour penetration.
Biotech
Founders & leadership
ZJ
Zahra JawadFounder
Investors Β· 4
Frequently asked questions
- What does Creasallis do?
- Creasallis develops CreaTap, a patented "plug-and-play" antibody modification technology that improves the penetration of antibody-based drugs into solid tumours, applicable to monoclonal, bispecific, and antibody-drug conjugates. It serves biopharmaceutical companies developing oncology therapeutics and is also building its own suite of antibody therapeutics with enhanced tumour penetration.
- Who founded Creasallis?
- Creasallis was founded by Zahra Jawad.
- Who are Creasallis's investors?
- Creasallis's investors include BlueYard Capital, Pace Ventures, ZAKA VC, KdT Ventures.